DeLiver Pharma ApS

CVR 39432714 · Private limited company (ApS) · Active · Low risk

DeLiver Pharma ApS is a Private limited company (ApS), founded on , based in Faaborg. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 163k and a net result of DKK -32k. CEO: Niels Jonas Heilskov Graversen.

Bankruptcy risk for DeLiver Pharma ApS

0.6%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 66% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years3+ · bankruptcy rate 41.0%4.7×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39432714
Status
Active
Company type
Private limited company (ApS)
Founded
(8 years)
Address
c/o Jonas Heilskov Graversen, Sanatorievej 8
5600 Faaborg
Municipality
Faaborg-Midtfyn
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 260k
Auditor
PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 8
Missing annual reportNo
Negative equityNo
Equity ratio92.5%
Current ratio840%
Moves (last 2 years)3
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyYes

Financials and key figures

Financial year202520242023
Gross profitDKK -20kDKK -10kDKK 119k
Net profitDKK -32kDKK -22kDKK 107k
EquityDKK 163kDKK 195kDKK 217k
Total assetsDKK 176kDKK 206kDKK 271k
CashDKK 110kDKK 128k–
Short-term debtDKK 13kDKK 11k–
Avg. employees00–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025176
1 Jan 2024 – 31 Dec 2024171
1 Jan 2023 – 31 Dec 2023179
1 Jan 2022 – 31 Dec 2022180
1 Jan 2021 – 31 Dec 2021138
1 Jan 2020 – 31 Dec 2020110
1 Jan 2019 – 31 Dec 2019175
9 Mar 2018 – 31 Dec 2018140

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONiels Jonas Heilskov GraversenCurrent
BoardJens Kristian DamsgaardCurrent
BoardNiels Jonas Heilskov GraversenCurrent
BoardSøren Kragh MoestrupCurrent
BoardHolger Jon MøllerCurrent
Owner (25%)MOESTRUP HOLDING 2007 ApSCurrent
Owner (25%)MØLLER HOLDING 2007 ApSCurrent
Owner (25%)PHIDEAS ApSCurrent
Owner (25%)SCIENCE VENTURES DENMARK A/SCurrent
FounderMOESTRUP HOLDING 2007 ApSCurrent
FounderMØLLER HOLDING 2007 ApSCurrent
FounderPHIDEAS ApSCurrent
FounderSCIENCE VENTURES DENMARK A/SCurrent

The CEOs' other companies

Niels Jonas Heilskov Graversen – 5 other companies

Address history (3 moves)

c/o Jonas Heilskov Graversen, Sanatorievej 8, 5600 Faaborg
c/o Jonas Heilskov Graversen, Fuglevej 21, 8592 Anholt
Sanatorievej 8, 5600 Faaborg
Tesdorpfsvej 12, 5000 Odense C

Other companies at the same address

Similar companies in Faaborg-Midtfyn

Questions and answers about DeLiver Pharma ApS

Has DeLiver Pharma ApS gone bankrupt?

No, DeLiver Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of DeLiver Pharma ApS?

Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of DeLiver Pharma ApS?

Niels Jonas Heilskov Graversen is the CEO of DeLiver Pharma ApS.

Who is the auditor of DeLiver Pharma ApS?

DeLiver Pharma ApS most recently used PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

When was DeLiver Pharma ApS founded?

DeLiver Pharma ApS was founded on 9 March 2018.

What is the equity of DeLiver Pharma ApS?

Equity was DKK 163k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.